Point72 Hong Kong LTD Immunity Bio, Inc. Transaction History

Point72 Hong Kong LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$2.68 - $6.14 $23,136 - $53,006	8,633 Added 140.4%	14,782 $55,000
Q1 2022 May 16, 2022	BUY	$5.05 - $7.53 $29,663 - $44,231	5,874 Added 2136.0%	6,149 $34,000
Q4 2021 Feb 14, 2022	BUY	$5.67 - $10.18 $1,559 - $2,799	275 New	275 $2,000
Q3 2021 Nov 15, 2021	SELL	$9.17 - $14.24 $2,842 - $4,414	-310 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$13.41 - $22.4 $4,157 - $6,944	310 New	310 $4,000

202

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.8B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.